Literature DB >> 16759149

Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens.

Cara C Bertozzi1, Cheng-Yi Chang, Sonya Jairaj, Xiaochuan Shan, Jia Huang, Barbara L Weber, Christina S Chu, Richard G Carroll.   

Abstract

To increase the efficiency of stable cell line establishment from primary ovarian cancer specimens, we simultaneously initiated cultures under multiple conditions, varying extracellular matrices and the inclusion of supplements (e.g., serum or serum albumin), while minimizing exposure to xenogeneic antigens (e.g., fetal calf serum). Primary cultures were initiated from 30 specimens; cell lines were established from 10 of these for a success rate of 33%. In some instances, multiple cell lines were established from the same specimen. Five lines were characterized extensively with respect to growth properties, antigen expression, and genomic alterations. Although these lines are all low-passage, marked heterogeneity was observed, even between lines derived from the same specimen. The culture approach outlined herein will facilitate generation of reagents useful for many aspects of ovarian cancer biology.

Entities:  

Mesh:

Year:  2006        PMID: 16759149     DOI: 10.1290/0512084.1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  40 in total

Review 1.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.

Authors:  S W Christianson; D L Greiner; R A Hesselton; J H Leif; E J Wagar; I B Schweitzer; T V Rajan; B Gott; D C Roopenian; L D Shultz
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

3.  Widespread intraspecies cross-contamination of human tumor cell lines arising at source.

Authors:  R A MacLeod; W G Dirks; Y Matsuo; M Kaufmann; H Milch; H G Drexler
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

Review 6.  Recent advances in immunohistochemistry in gynaecological pathology.

Authors:  W G McCluggage
Journal:  Histopathology       Date:  2002-04       Impact factor: 5.087

7.  Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

Authors:  H Iwabuchi; M Sakamoto; H Sakunaga; Y Y Ma; M L Carcangiu; D Pinkel; T L Yang-Feng; J W Gray
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

8.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

Review 10.  Immunotherapeutic potential of whole tumour cells.

Authors:  Stephen Ward; David Casey; Marie-Christine Labarthe; Michael Whelan; Angus Dalgleish; Hardev Pandha; Stephen Todryk
Journal:  Cancer Immunol Immunother       Date:  2002-06-14       Impact factor: 6.968

View more
  12 in total

1.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

Review 2.  Adoptive immunotherapy: good habits instilled at youth have long-term benefits.

Authors:  Chrystal M Paulos; Megan M Suhoski; Gabriela Plesa; Tianying Jiang; Samik Basu; Tatiana N Golovina; Shuguang Jiang; Nicole A Aqui; Daniel J Powell; Bruce L Levine; Richard G Carroll; James L Riley; Carl H June
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.

Authors:  Edmund K Moon; Carmine Carpenito; Jing Sun; Liang-Chuan S Wang; Veena Kapoor; Jarrod Predina; Daniel J Powell; James L Riley; Carl H June; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

4.  The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy.

Authors:  Emese Zsiros; Priyanka Duttagupta; Denarda Dangaj; Hongzhe Li; Renee Frank; Thomas Garrabrant; Ian S Hagemann; Bruce L Levine; Carl H June; Lin Zhang; Ena Wang; Francesco M Marincola; Davide Bedognetti; Daniel J Powell; Janos Tanyi; Michael D Feldman; Lana E Kandalaft; George Coukos
Journal:  Clin Cancer Res       Date:  2015-02-23       Impact factor: 12.531

5.  Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Authors:  Brian J Cameron; Andrew B Gerry; Joseph Dukes; Jane V Harper; Vivekanandan Kannan; Frayne C Bianchi; Francis Grand; Joanna E Brewer; Minnal Gupta; Gabriela Plesa; Giovanna Bossi; Annelise Vuidepot; Alex S Powlesland; Alison Legg; Katherine J Adams; Alan D Bennett; Nicholas J Pumphrey; Daniel D Williams; Gwendolyn Binder-Scholl; Irina Kulikovskaya; Bruce L Levine; James L Riley; Angel Varela-Rohena; Edward A Stadtmauer; Aaron P Rapoport; Gerald P Linette; Carl H June; Namir J Hassan; Michael Kalos; Bent K Jakobsen
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

6.  Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells.

Authors:  Catherine E Wharry; Kathleen M Haines; Richard G Carroll; Michael J May
Journal:  Cancer Biol Ther       Date:  2009-08-08       Impact factor: 4.742

7.  Monoclonal TCR-redirected tumor cell killing.

Authors:  Nathaniel Liddy; Giovanna Bossi; Katherine J Adams; Anna Lissina; Tara M Mahon; Namir J Hassan; Jessie Gavarret; Frayne C Bianchi; Nicholas J Pumphrey; Kristin Ladell; Emma Gostick; Andrew K Sewell; Nikolai M Lissin; Naomi E Harwood; Peter E Molloy; Yi Li; Brian J Cameron; Malkit Sami; Emma E Baston; Penio T Todorov; Samantha J Paston; Rebecca E Dennis; Jane V Harper; Steve M Dunn; Rebecca Ashfield; Andy Johnson; Yvonne McGrath; Gabriela Plesa; Carl H June; Michael Kalos; David A Price; Annelise Vuidepot; Daniel D Williams; Deborah H Sutton; Bent K Jakobsen
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

8.  Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.

Authors:  Joseph R Francica; Angel Varela-Rohena; Andrew Medvec; Gabriela Plesa; James L Riley; Paul Bates
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

9.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

10.  Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels.

Authors:  Evripidis Lanitis; Denarda Dangaj; Ian S Hagemann; De-Gang Song; Andrew Best; Raphael Sandaltzopoulos; George Coukos; Daniel J Powell
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.